about
mission / vision
our team
board members
executive leadership
scientists
careers
postdoctoral programs
internship programs
current job opportunities
| |
 |
Gregory C. Ireton, PhD
Scientist II
Greg Ireton is a Scientist II at IDRI. Greg currently works on
projects related to the biochemical characterization and
development of IDRI's next generation vaccine for
leishmaniasis. He is also focused on leprosy antigen
discovery, using bioinformatics to aid in the selection and
design of new candidate antigens for the development of
improved rapid diagnostic tests for leprosy.
Prior to joining IDRI, Greg worked as a research technician
in the Department of Microbiology at the University of
Washington, focusing on the biochemical and kinetic
properties of human topoisomerase I with the anti-tumor
drug camptothecin. He collaborated with scientists at
Washington State University working on enzymes for novel
cancer therapies, and performed postgraduate work towards
his thesis, "Structural studies of yeast and bacterial cytosine
deaminases: directed evolution and implications for anticancer
gene therapy."
Greg obtained his BSc with honors in Microbiology from the
University of Washington in 1994. He then entered graduate
studies in the Molecular and Cellular Biology Program at
the University of Washington, studying protein x-ray
crystallography and protein design in the laboratory of Barry
Stoddard at the Fred Hutchinson Cancer Research Center.
He received his PhD from the University of Washington
in 2003.
|
|
